National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Public ClinicalTrials.gov record NCT01322165. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) was initiated in 2006 by the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). GenTAC established a registry of 3706 patients with genetic conditions that may be related to thoracic aortic aneurysms and collected medical data and biologic samples. The study ended in September 2016. Data and samples are available from NHLBI and requests should be made to BioLINCC. See the NHLBI website for more information: https://www.nhlbi.nih.gov/research/resources/gentac/.
Study identification
- NCT ID
- NCT01322165
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 3,706 participants
Conditions and interventions
Conditions
- Marfan Syndrome
- Turner Syndrome
- Ehlers-Danlos Syndrome
- Loeys-Dietz Syndrome
- FBN1, TGFBR1, TGFBR2, ACTA2 or MYH11 Genetic Mutation
- Bicuspid Aortic Valve Without Known Family History
- Bicuspid Aortic Valve With Family History
- Bicuspid Aortic Valve With Coarctation
- Familial Thoracic Aortic Aneurysm and Dissections
- Shprintzen-Goldberg Syndrome
- Other Aneur/Diss of Thoracic Aorta Not Due to Trauma, <50yo
- Other Congenital Heart Disease
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2007
- Primary completion
- Aug 31, 2015
- Completion
- Aug 31, 2016
- Last update posted
- Dec 19, 2016
2007 – 2016
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Queens Medical Center | Honolulu | Hawaii | 96813 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| The New York Presbyterian Hospital-Weill Cornell Medical Center | New York | New York | 10021 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| University of Pennsylvania School of Medicine | Philadelphia | Pennsylvania | 19104-4283 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| University of Texas Medical School at Houston | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01322165, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2016 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01322165 live on ClinicalTrials.gov.